MedPath

SaNOtize Research and Development Corp

SaNOtize Research and Development Corp logo
🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis

Phase 2
Active, not recruiting
Conditions
Recurrent Acute Rhinosinusitis
Interventions
Drug: Nitric Oxide Releasing Solution
Device: Nasal spray with isotonic saline
First Posted Date
2024-02-16
Last Posted Date
2025-01-06
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
162
Registration Number
NCT06264141
Locations
🇨🇦

Okanegan Clinical Trials, Kelowna, British Columbia, Canada

🇨🇦

Alpha Recherche Clinique LeBourneuf, Québec City, Quebec, Canada

🇨🇦

Richmond Clinical Trials (Okanagan Clinical Trials Satelite Site), Richmond, British Columbia, Canada

and more 4 locations

Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

Phase 1
Completed
Conditions
Candidiasis, Oral
Interventions
First Posted Date
2023-11-07
Last Posted Date
2024-07-10
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
6
Registration Number
NCT06120816
Locations
🇨🇦

Atlantis Dental Cambie, Vancouver, British Columbia, Canada

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Phase 2
Completed
Conditions
Verruca Plantaris
Interventions
Other: Sterile water foot bath
First Posted Date
2023-05-26
Last Posted Date
2024-04-17
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
20
Registration Number
NCT05877313
Locations
🇨🇦

Achilles Foot Health Centre, Surrey, British Columbia, Canada

🇨🇦

Pacific Derm, Vancouver, British Columbia, Canada

🇨🇦

Spectrum Health, Vancouver, British Columbia, Canada

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

Phase 3
Completed
Conditions
SARS-CoV-2 Infection
Interventions
First Posted Date
2022-10-31
Last Posted Date
2022-10-31
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
306
Registration Number
NCT05599919
Locations
🇮🇳

Aster Prime Hospital, Hyderabad, India

🇮🇳

Orchid Specialty Hospital, Lohgaon, India

🇮🇳

Bangalore Medical College and Research Institute, Bangalore, India

and more 18 locations

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

Phase 3
Active, not recruiting
Conditions
SARS-CoV-2 Infection
Interventions
Device: Nasal spray with isotonic saline
First Posted Date
2021-11-05
Last Posted Date
2023-05-06
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
1389
Registration Number
NCT05109611
Locations
🇱🇰

National Institute of Infectious Diseases Hospital, Angoda, Angoda, Sri Lanka

🇱🇰

Puttalam Base Hospital,, Puttalam, Sri Lanka

🇨🇦

Medical Trust Clinics , Inc, Oshawa, Ontario, Canada

and more 3 locations

Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers

Phase 1
Completed
Conditions
Diabetic Foot Ulcer
Interventions
Drug: Nitric Oxide-Releasing Solution
Drug: Saline solution, hypotonic
First Posted Date
2021-02-16
Last Posted Date
2023-05-31
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
40
Registration Number
NCT04755647
Locations
🇨🇦

Achilles Foot Health Centre, Vancouver, British Columbia, Canada

Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

Phase 2
Withdrawn
Conditions
SARS-CoV Infection
Interventions
Drug: Nitric Oxide-Releasing Drug
First Posted Date
2020-06-23
Last Posted Date
2021-07-16
Lead Sponsor
Sanotize Research and Development corp.
Registration Number
NCT04443868

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

Phase 2
Completed
Conditions
Corona Virus Infection
Interventions
Drug: NORS (Nitric Oxide Releasing Solution)
First Posted Date
2020-04-08
Last Posted Date
2021-02-10
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
143
Registration Number
NCT04337918
Locations
🇨🇦

BC Diabetes, Vancouver, British Columbia, Canada

🇨🇦

Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada

🇨🇦

Diex Recherche Québec, Québec, Quebec, Canada

and more 2 locations

Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)

Phase 2
Completed
Conditions
Chronic Sinusitis
Interventions
First Posted Date
2019-11-15
Last Posted Date
2022-06-30
Lead Sponsor
Sanotize Research and Development corp.
Target Recruit Count
56
Registration Number
NCT04163978
Locations
🇨🇦

St. Paul's Hospital, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath